← Leaderboards
Jennifer Jao
Icahn School Of Medicine At Mount Sinai
$11,042,167
Attributed
$23,135,868
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $22.4M · FY2012–25$25M$18.8M$12.5M$6.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$119,511,410 · 9
By mechanism
P01$88,304,328 · 1
R01$18,651,038 · 3
U19$8,071,214 · 1
R33$2,504,560 · 1
R61$841,208 · 1
K23$646,762 · 1
Top collaborators
- Paige L Williams10 shared
- Ellen Gould Chadwick9 shared
- Sonia Hernandez-Diaz9 shared
- Joseph Moeketsi Makhema7 shared
- Kathleen Powis7 shared
- Elaine Janine Abrams5 shared
- Benjamin Landon Myer5 shared
- Heather Joy Zar5 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Nathan E Goldstein$9,630,744
- Bryan Thomas Denny$2,259,305
- Melissa Diane Aldridge$12,822,818
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildExposure ToAnti-Retroviral AgentsCohortPharmaceutical PreparationsIn UteroPregnant WomenResearch InfrastructureMetabolicInsulin ResistanceInfantAntiretroviral TherapyHiv InfectionsWomanPublic HealthFutureDesignAdolescentLifeRegimenCardiometabolismRisk FactorsLife Cycle StagesGrowth
Grant awards (39)
Pediatric HIV/AIDS Cohort Study (PHACS): Research on Immune Aging, Supporting Reproductive Health, and Perinatal Acquisition: Elucidating Relationships in HIV (RISE)$8,071,214
U19 · FY2025 · HD
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$17,150,732
P01 · FY2024 · HD
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,452,419
R01 · FY2024 · HD
Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV$638,591
R01 · FY2024 · HL · contact PI
FLOURISH - Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescent who are HIV Exposed Uninfected$587,293
R33 · FY2024 · HD
Disclosure Intervention to Support Caregivers (DISC)$336,391
R33 · FY2024 · HD
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$217,850
P01 · FY2024 · HD
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$17,150,816
P01 · FY2023 · HD
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,717,846
R01 · FY2023 · HD
Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV$693,765
R01 · FY2023 · HL · contact PI
FLOURISH - Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescent who are HIV Exposed Uninfected$612,768
R33 · FY2023 · HD
Admin Sup FACET: Family Dynamics and Child Neurodevelopment in Botswana$287,707
R33 · FY2023 · HD
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$17,600,741
P01 · FY2022 · HD
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,491,998
R01 · FY2022 · HD
FLOURISH - Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescent who are HIV Exposed Uninfected$680,401
R33 · FY2022 · HD
Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV$550,840
R01 · FY2022 · HL · contact PI
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$17,457,932
P01 · FY2021 · HD
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,294,356
R01 · FY2021 · HD
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$803,491
P01 · FY2021 · HD
Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV$656,604
R01 · FY2021 · HL · contact PI
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$450,000
P01 · FY2021 · HD
FLOURISH - Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescent who are HIV Exposed Uninfected$409,985
R61 · FY2021 · HD
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$322,285
P01 · FY2021 · HD
Pediatric HIV/AIDS Cohort Study (PHACS) 2020$17,150,481
P01 · FY2020 · HD
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,382,926
R01 · FY2020 · HD
Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV$733,852
R01 · FY2020 · HL · contact PI
The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-Exposed Uninfected in Botswana$578,056
R01 · FY2020 · DK · contact PI
FLOURISH - Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescent who are HIV Exposed Uninfected$431,223
R61 · FY2020 · HD
The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-Exposed Uninfected in Botswana$578,121
R01 · FY2019 · DK · contact PI
The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-Exposed Uninfected in Botswana$629,835
R01 · FY2018 · DK · contact PI
Metabolomic Signatures of Insulin Resistance and Visceral Adiposity Changes in HIV-infected Adults on Newer Line Antiretroviral Therapy$140,873
R21 · FY2018 · DK · contact PI
The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-Exposed Uninfected in Botswana$645,360
R01 · FY2017 · DK · contact PI
Metabolomic Signatures of Insulin Resistance and Visceral Adiposity Changes in HIV-infected Adults on Newer Line Antiretroviral Therapy$351,427
R21 · FY2017 · DK · contact PI
The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-exposed uninfected in Botswana$606,469
R01 · FY2016 · DK · contact PI
Metabolic Effects of In Utero Antiretrovirals on HIV Exposed Uninfected Infants$129,346
K23 · FY2016 · HD · contact PI
Metabolic Effects of In Utero Antiretrovirals on HIV Exposed Uninfected Infants$129,354
K23 · FY2015 · HD · contact PI
Metabolic Effects of In Utero Antiretrovirals on HIV Exposed Uninfected Infants$129,354
K23 · FY2014 · HD · contact PI
Metabolic Effects of In Utero Antiretrovirals on HIV Exposed Uninfected Infants$129,354
K23 · FY2013 · HD · contact PI
Metabolic Effects of In Utero Antiretrovirals on HIV Exposed Uninfected Infants$129,354
K23 · FY2012 · HD · contact PI